Related Experiment Video
Updated: Jul 7, 2026

Affinity Purification of Influenza Virus Ribonucleoprotein Complexes from the Chromatin of Infected Cells
Published on: June 3, 2012
Structural basis for the function and inhibition of an influenza virus proton channel
Amanda L Stouffer1, Rudresh Acharya, David Salom
1Department of Biochemistry and Biophysics, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Abstract:
The M2 protein from influenza A virus is a pH-activated proton channel that mediates acidification of the interior of viral particles entrapped in endosomes. M2 is the target of the anti-influenza drugs amantadine and rimantadine; recently, resistance to these drugs in humans, birds and pigs has reached more than 90% (ref. 1). Here we describe the crystal structure of the transmembrane-spanning region of the homotetrameric protein in the presence and absence of the channel-blocking drug amantadine. pH-dependent structural changes occur near a set of conserved His and Trp residues that are involved in proton gating. The drug-binding site is lined by residues that are mutated in amantadine-resistant viruses. Binding of amantadine physically occludes the pore, and might also perturb the pK(a) of the critical His residue. The structure provides a starting point for solving the problem of resistance to M2-channel blockers.
Insights
The influenza A virus M2 protein structure reveals how amantadine blocks proton flow. Understanding this mechanism is crucial for developing new drugs against widespread drug-resistant influenza strains.
Area of Science:
- Structural biology
- Virology
- Drug discovery
Background:
- Influenza A virus M2 protein functions as a pH-activated proton channel.
- Amantadine and rimantadine are anti-influenza drugs targeting the M2 channel.
- Widespread resistance (>90%) to amantadine and rimantadine necessitates new therapeutic strategies.
Purpose of the Study:
- To determine the crystal structure of the M2 protein's transmembrane region.
- To elucidate the structural basis of amantadine's interaction with the M2 channel.
- To provide insights into the mechanisms of amantadine resistance.
Main Methods:
- X-ray crystallography was used to obtain the structure of the M2 protein's transmembrane domain.
- Structures were determined in the presence and absence of the drug amantadine.
- Analysis of conserved residues and drug-binding sites was performed.
Main Results:
- The crystal structure of the homotetrameric M2 protein transmembrane region was solved.
- pH-dependent structural changes involving conserved His and Trp residues were identified.
- The amantadine-binding site was characterized, revealing its occlusion of the proton pore.
- Mutations conferring amantadine resistance were found to line the drug-binding site.
Conclusions:
- The determined structure provides a molecular basis for amantadine's channel-blocking activity.
- Structural insights explain how amantadine resistance mutations affect drug binding.
- This structural information serves as a foundation for designing new M2 channel blockers to overcome drug resistance.
More Related Videos
Related Concept Videos
Inhibitors Of Virion Release
Influenza
Leaky Scanning
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Inhibitors of Viral Protein Synthesis
Inhibitors of Virion Maturation and Assembly

